Celecoxib activates Stat5 and restores or increases the expression of growth hormone-regulated genes in hepatocarcinogenesis

Anti-Cancer Drugs

Volumn 21, Issue 4, 2010, Pages 411-422

  Arellanes Robledo, Jaime ^a   Salcido Neyoy, Martha Estela ^b   Márquez Quiñones, Adriana ^a   García Román, Rebeca ^c   Beltrán Ramírez, Olga ^a   Le Berre, Véronique ^d   Sokol, Sergueï ^d   François, Jean Marie ^d   Villa Trevino, Saúl ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b Institut national du cancer du Canada   (Canada)

^c UNIVERSIDAD VERACRUZANA   (Mexico)

^d INSA   (France)

Author keywords

Alpha2 urinary globulin; Celecoxib; Chemoprevention; Cytochrome P450; Gene expression profile; Hepatocarcinogenesis; Stat5

Indexed keywords

ALPHA 2 GLOBULIN; CELECOXIB; CYTOCHROME P450 2B; CYTOCHROME P450 2B1; CYTOCHROME P450 2B2; CYTOCHROME P450 2B3; CYTOCHROME P450 3A1; DNA; GROWTH HORMONE; MESSENGER RNA; STAT5 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DIET; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; UPREGULATION; WESTERN BLOTTING;

ALPHA-GLOBULINS; ANIMALS; ANTINEOPLASTIC AGENTS; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP2B1; GENE EXPRESSION; GENE EXPRESSION PROFILING; GROWTH HORMONE; LIVER NEOPLASMS, EXPERIMENTAL; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; STAT5 TRANSCRIPTION FACTOR; STEROID HYDROXYLASES; SULFONAMIDES;

EID: 77949403908     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/CAD.0b013e328336e907     Document Type: Article

References (41)

1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132:2557-2576.
2. Narayanan BA. Chemopreventive agents alters global gene expression pattern: predicting their mode of action and targets. Curr Cancer Drug Targets 2006; 6:711-727.
3. Grosch S, Maier TJ, Schiffmann S, Geisslinger G. Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors. J Natl Cancer Inst 2006; 98:736-747.
4. Marquez-Rosado L, Trejo-Solis MC, Garcia-Cuellar CM, Villa-Trevino S. Celecoxib, a cyclooxygenase-2 inhibitor, prevents induction of liver preneoplastic lesions in rats. J Hepatol 2005; 43:653-660.
5. Arellanes-Robledo J, Marquez-Rosado L, Perez-Carreon JI, Fattel-Fazenda S, Aguirre-Garcia J, Villa-Trevino S. Celecoxib induces regression of putative preneoplastic lesions in rat liver. Anticancer Res 2006; 26:1271-1280.
6. Herrington J, Smit LS, Schwartz J, Carter-Su C. The role of STAT proteins in growth hormone signaling. Oncogene 2000; 19:2585-2597.
7. Clodfelter KH, Miles GD,Wauthier V, Holloway MG, Zhang X, Hodor P, et al. Role of STAT5a in regulation of sex-specific gene expression in female but not male mouse liver revealed by microarray analysis. Physiol Genomics 2007; 31:63-74.
8. Clodfelter KH, Holloway MG, Hodor P, Park SH, Ray WJ, Waxman DJ. Sex-dependent liver gene expression is extensive and largely dependent upon signal transducer and activator of transcription 5b (STAT5b): STAT5bdependent activation of male genes and repression of female genes revealed by microarray analysis. Mol Endocrinol 2006; 20:1333-1351.
9. Bernhardt R. Cytochromes P450 as versatile biocatalysts. J Biotechnol 2006; 124:128-145.
10. Flower DR. The lipocalin protein family: structure and function. Biochem J 1996; 318 (Pt 1):1-14.
11. Waxman DJ, O'Connor C. Growth hormone regulation of sex-dependent liver gene expression. Mol Endocrinol 2006; 20:2613-2629.
12. Roy AK, Chatterjee B, Demyan WF, Nath TS, Motwani NM. Pretranslational regulation of alpha 2u-globulin in rat liver by growth hormone. J Biol Chem 1982; 257:7834-7838.
13. Marquez-Quinones A, Paris A, Roussel B, Perez-Carreon J, Le Berre V, Francois JM, et al. Proteasome activity deregulation in LEC rat hepatitis: following the insights of transcriptomic analysis. Omics 2007; 11:367-384.
14. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002; 30:e15.
15. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25:402-408.
16. Mayer RT, Netter KJ, Heubel F, Hahnemann B, Buchheister A, Mayer GK, et al. 7-Alkoxyquinolines: new fluorescent substrates for cytochrome P450 monooxygenases. Biochem Pharmacol 1990; 40:1645-1655.
17. Blobel G, Potter VR. Nuclei from rat liver: isolation method that combines purity with high yield. Science 1966; 154:1662-1665.
18. Kulkarni AB, Gubits RM, Feigelson P. Developmental and hormonal regulation of alpha 2u-globulin gene transcription. Proc Natl Acad Sci U S A 1985; 82:2579-2582.
19. Henkens T, Vinken M, Vanhaecke T, Rogiers V. Modulation of CYP1A1 and CYP2B1 expression upon cell cycle progression in cultures of primary rat hepatocytes. Toxicol In vitro 2007; 21:1253-1257.
20. Shaw PM, Edigkaufer M, Doehmer J, Adesnik M. Sequence of the rat PB-inducible CYP2B1 promoter. Biochim Biophys Acta 1996; 1305:54-58.
21. Samadani U, Costa RH. The transcriptional activator hepatocyte nuclear factor 6 regulates liver gene expression. Mol Cell Biol 1996; 16:6273-6284.
22. Lahuna O, Rastegar M, Maiter D, Thissen JP, Lemaigre FP, Rousseau GG. Involvement of STAT5 (signal transducer and activator of transcription 5) and HNF-4 (hepatocyte nuclear factor 4) in the transcriptional control of the hnf6 gene by growth hormone. Mol Endocrinol 2000; 14:285-294.
23. Quidville V, Segond N, Tebbi A, Cohen R, Jullienne A, Lepoivre M, et al. Anti-tumoral effect of a celecoxib low dose on a model of human medullary thyroid cancer in nude mice. Thyroid 2009; 19:613-621.
24. Williams CS,Watson AJ, Sheng H, Helou R, Shao J, DuBois RN. Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models. Cancer Res 2000; 60:6045-6051.
25. Pedraza-Farina LG. Mechanisms of oncogenic cooperation in cancer initiation and metastasis. Yale J Biol Med 2006; 79:95-103.
26. Salcido-Neyoy ME, Sierra-Santoyo A, Beltran-Ramirez O, Macias-Perez JR, Villa-Trevino S. Celecoxib enhances the detoxification of diethylnitrosamine in rat liver cancer. World J Gastroenterol 2009; 15:2345-2350.
27. Manson MM, Hudson EA, Ball HW, Barrett MC, Clark HL, Judah DJ, et al. Chemoprevention of aflatoxin B1-induced carcinogenesis by indole-3- carbinol in rat liver - predicting the outcome using early biomarkers. Carcinogenesis 1998; 19:1829-1836.
28. Zhu B, Liu GT, Wu RS, Strada SJ. Chemoprevention of bicyclol against hepatic preneoplastic lesions. Cancer Biol Ther 2006; 5:1665-1673.
29. Canistro D, Croce CD, Iori R, Barillari J, Bronzetti G, Poi G, et al. Genetic and metabolic effects of gluconasturtiin, a glucosinolate derived from cruciferae. Mutat Res 2004; 545:23-35.
30. Imaoka S, Osada M, Minamiyama Y, Yukimura T, Toyokuni S, Takemura S, et al. Role of phenobarbital-inducible cytochrome P450s as a source of active oxygen species in DNA-oxidation. Cancer Lett 2004; 203:117-125.
31. Beltran-Ramirez O, Aleman-Lazarini L, Salcido-Neyoy M, Hernandez-Garcia S, Fattel-Fazenda S, Arce-Popoca E, et al. Evidence that the anticarcinogenic effect of caffeic acid phenethyl ester in the resistant hepatocyte model involves modifications of cytochrome P450. Toxicol Sci 2008; 104:100-106.
32. Liu LL, Gong LK, Qi XM, Cai Y,Wang H,Wu XF, et al. Altered expression of cytochrome P450 and possible correlation with preneoplastic changes in early stage of rat hepatocarcinogenesis. Acta Pharmacol Sin 2005; 26:737-744.
33. Koenig S, Aurich H, Schneider C, Krause P, Haftendorn R, Becker H, et al. Zonal expression of hepatocytic marker enzymes during liver repopulation. Histochem Cell Biol 2007; 128:105-114.
34. Matuoka K, Markus I, Wong A, Smith GJ. Diethylnitrosamine- and partial hepatectomy-induced decrease in alpha 2u-globulin mRNA level in the rat liver. J Cancer Res Clin Oncol 1993; 119:572-575.
35. Corton JC, Fan LQ, Brown S, Anderson SP, Bocos C, Cattley RC, et al. Down-regulation of cytochrome P450 2C family members and positive acute-phase response gene expression by peroxisome proliferator chemicals. Mol Pharmacol 1998; 54:463-473.
36. Mirpuri E, Garcia-Trevijano ER, Castilla-Cortazar I, Berasain C, Quiroga J, Rodriguez-Ortigosa C, et al. Altered liver gene expression in CCl4-cirrhotic rats is partially normalized by insulin-like growth factor-I. Int J Biochem Cell Biol 2002; 34:242-252.
37. Escrich E, Moral R, Garcia G, Costa I, Sanchez JA, Solanas M. Identification of novel differentially expressed genes by the effect of a high-fat n-6 diet in experimental breast cancer. Mol Carcinog 2004; 40:73-78.
38. Bhattacharyya S, Mandal D, Saha B, Sen GS, Das T, Sa G. Curcumin prevents tumor-induced T cell apoptosis through Stat-5a-mediated Bcl-2 induction. J Biol Chem 2007; 282:15954-15964.
39. Nevalainen MT, Xie J, Torhorst J, Bubendorf L, Haas P, Kononen J, et al. Signal transducer and activator of transcription-5 activation and breast cancer prognosis. J Clin Oncol 2004; 22:2053-2060.
40. Li H, Zhang Y, Glass A, Zellweger T, Gehan E, Bubendorf L, et al. Activation of signal transducer and activator of transcription-5 in prostate cancer predicts early recurrence. Clin Cancer Res 2005; 11:5863-5868.
41. Lee TK, Man K, Poon RT, Lo CM, Yuen AP, Ng IO, et al. Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial - mesenchymal transition. Cancer Res 2006; 66:9948-9956.